WH
WuXi Healthcare Ventures
WuXi Healthcare Ventures is a Series A to Series C stage investment firm. It has made 16 investments. 43% of their portfolio is in Biotech & Life Sciences. Average disclosed round size is $68.2M (across 22 rounds with reported amounts).
Portfolio
16
Fund Size
—
Top Stage
Series B
Last 12 Mo
0
Team
AJ
Alexis Ji
Founding Partner
GL
Ge Li
Founding Partner
WL
Wei Li
Director of General Partner
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
23 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 LifeMine Therapeutics | Series B | $50M | Jan 2021 |
 Hao Xin Qing | Series A | $125M | May 2020 |
 CStone Pharmaceuticals | Series B | $260M | May 2018 |
| RRefuge Biotechnologies | Series B | $25M | May 2018 |
 IDEAYA Biosciences | Series B | $94M | Mar 2018 |
| IIdeaya | Series B | $94M | Mar 2018 |
| UUltivue | Series B | $20M | Jan 2018 |
 Medeor Therapeutics | Series B | $57M | Nov 2017 |
 23andMe, Inc. | Series E | $250M | Sep 2017 |
 Vivace Therapeutics | Series B | $25M | Jun 2017 |
| LifeMine Therapeutics | Series A | $55M | Jan 2017 |
 Avelas Biosciences | Series C | $20M | Aug 2016 |
| IIdeaya | Series A | — | May 2016 |
 Syros Pharmaceuticals | Series C | $40M | Jan 2016 |
| Syros Pharmaceuticals | Series A | $30M | Jan 2016 |
| LifeMine Therapeutics | Seed | $5M | Jan 2016 |
| CStone Pharmaceuticals | Series A | $150M | Jan 2016 |
| AAltheaDx | Series C | $30M | Dec 2015 |
 23andMe | Series E | $115M | Jan 2015 |
| Vivace Therapeutics | Series A | $15M | Jan 2015 |
| LLumo Bodytech | Series A | $5M | Dec 2012 |
| RRefuge Biotech | Unknown | $25M | — |
| LLumo Bodytech | Series B | $10M | — |
Top Co-Investors
WuXi AppTec8 shared
Alexandria Venture Investments6 shared
GV5 shared
Canaan Partners5 shared
ARCH Venture Partners5 shared
HongShan4 shared
Casdin Capital3 shared
Fidelity Investments3 shared
Celgene3 shared
Boyu Capital3 shared
GG13 shared
ShangBay Capital2 shared
3E Bioventures Capital2 shared
Danhua Capital2 shared
Sequoia Capital2 shared
Dimension2 shared
Oriza Seed Venture Capital2 shared
Polaris Partners2 shared
Redmile Group2 shared
Last updated: 20 October 2026